These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14531077)

  • 21. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
    Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
    Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
    Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
    J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A horseradish peroxidase-light and electron microscopic study of immunoliposomes utilized for intracellular delivery to the rat striatum.
    Sheehan JP; Sheehan JM; Holmberg EG; Geisert EE; Helm GA
    Neurosci Lett; 2002 Nov; 333(3):212-6. PubMed ID: 12429385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-directed targeting of liposomes.
    Park YS
    Biosci Rep; 2002 Apr; 22(2):267-81. PubMed ID: 12428904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.
    Bestman-Smith J; Gourde P; Désormeaux A; Tremblay MJ; Bergeron MG
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):161-74. PubMed ID: 11018661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics.
    Carrion C; Domingo JC; de Madariaga MA
    Chem Phys Lipids; 2001 Nov; 113(1-2):97-110. PubMed ID: 11687230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
    Mori A; Kennel SJ; Huang L
    Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates.
    Savellano MD; Hasan T
    Photochem Photobiol; 2003 Apr; 77(4):431-9. PubMed ID: 12733655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.
    Elbayoumi TA; Torchilin VP
    Eur J Pharm Sci; 2007 Nov; 32(3):159-68. PubMed ID: 17707615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes.
    Rothdiener M; Beuttler J; Messerschmidt SK; Kontermann RE
    Methods Mol Biol; 2010; 624():295-308. PubMed ID: 20217604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.
    Schuster L; Seifert O; Vollmer S; Kontermann RE; Schlosshauer B; Hartmann H
    Mol Pharm; 2015 Sep; 12(9):3146-57. PubMed ID: 26181293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.
    Siwak DR; Tari AM; Lopez-Berestein G
    Clin Cancer Res; 2002 Apr; 8(4):955-6. PubMed ID: 11948099
    [No Abstract]   [Full Text] [Related]  

  • 35. Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
    Pincus SH; Song K; Maresh GA; Frank A; Worthylake D; Chung HK; Polacino P; Hamer DH; Coyne CP; Rosenblum MG; Marks JW; Chen G; Weiss D; Ghetie V; Vitetta ES; Robinson JE; Hu SL
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27795412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.
    Hansen CB; Kao GY; Moase EH; Zalipsky S; Allen TM
    Biochim Biophys Acta; 1995 Nov; 1239(2):133-44. PubMed ID: 7488618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nanostructured liposomal systems as transport agents for anticancer drugs].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
    Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
    Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation and in vitro tumor cells selectivity of sterically stabilized immunoliposomal peptides in bee venom].
    Hu HY; Chen DW; Liu YF; Qiao MX; Zhao XL
    Yao Xue Xue Bao; 2007 Nov; 42(11):1201-5. PubMed ID: 18300479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.